The MarketsandMarkets Biomarker and Companion Diagnostics Conference is dedicated to biomarkers and technologies that drive precision medicine and translational research, biomarkers for cancer as well as issues related to clinical translation of biomarkers.
Topics
- Proteomics and genomics based biomarkers
- Commercialization of cdx
- Multiplex companion diagnostics and regulatory guidelines
- Biomarker drug discovery and assay development
- Digital biomarkers, predictive biomarkers, precision medicine, and big data
- Design of clinical trials in cdx
- Clinical applications of biomarkers in immuno-oncology, neurology, and inflammatory diseases
Who should Attend
Attendees researchers, scientists, clinicians, academicians and professionals from pharmaceutical/biotech companies and academic institutions involved or interested in:
- Translational research
- Biomarker discovery/development
- Biomarkers in IO and Neurological disorders
- Clinical Biomarker
- Pathology
- Imaging Biomarkers
- Biomarker Imaging
- Companion Diagnostics
- Experimental Medicine
- Proteomics Biomarkers
- Biomarkers in Clinical Discovery
- Data Science
- Diagnostic Biomarkers development
- Immuno-oncology/Neuroscience Drug Discovery
- Immunology Biomarkers
- Personalized Medicine
